Synthesis and Biological Screening of 4-Benzyl-2H-phthalazine Derivatives

Pharmaceuticals

Volumn 4, Issue 8, 2011, Pages 1158-1170

  El Wahab, Ashraf H F Abd ^a,b   Mohamed, Hany M ^a,b   El Agrody, Ahmed M ^c   El Nassag, Mohammed A ^a   Bedair, Ahmed H ^a  

^a Assiut Branch   (Egypt)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Anthracene derivatives; Antimicrobial activity; Phthalazine derivatives; Synthesis

Indexed keywords

(4 BENZYL 1 OXO 1H PHTHALAZIN 2 YL)ACETIC ACID HYDRAZIDE; (4 BENZYLPHTHALAZIN 1 YLAMINO)PHENOL; 1 [(4 BENZYLPHTHALAZIN 1 YLAMINO)PHENYL]ETHANONE; 2 [4 (4 BENZYLPHTHALAZIN 1 YLAMINO)BENZAMIDO]ACETAMIDE; 4 (4 BENZYLPHTHALAZIN 1 YLAMINO)ACETANILIDE; 4 (4 BENZYLPHTHALAZIN 1 YLAMINO)BENZENESULFONIC ACID; 4 (4 BENZYLPHTHALAZIN 1 YLAMINO)BENZOIC ACID; 4 (4 BENZYLPHTHALAZIN 1 YLAMINO)DIPHENYL AMINE; 4 AMINO 2 [N' (4 BENZYLPHTHALAZIN 1 YL)HYDRAZINO] 6 (4 CHLOROPHENYL)PYRIMIDINE 5 CARBONITRILE; 4 AMINO 2 [N' (4 BENZYLPHTHALAZIN 1 YL)HYDRAZINO] 6 (4 METHOXYPHENYL)PYRIMIDINE 5 CARBONITRILE; 4 BENZYL 2 CHLOROMETHYL 2H PHTHALAZIN 1 ONE; 4 BENZYL 2 HYDROXYMETHYL 2H PHTHALAZIN 1 ONE; 4 BENZYL 2 MERCAPTOMETHYL 2H PHTHALAZIN 1 ONE; 4 BENZYL 2 THIOCYANATOMETHYL 2H PHTHALAZIN 1 ONE; 5 BENZYL 6,6A,12 TRIAZOBENZO[A]ANTHRACEN 7 ONE; 7 (4 BENZYLPHTHALAZIN 1 YLAMINO) 4 HYDROXYNAPHTHALENE 2 SULFONIC ACID; 7 (4 BENZYLPHTHALAZIN 1 YLAMINO)NAPHTHALEN 2 OL; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ETHYL (4 BENZYL 1 OXO 1H PHTHALAZIN 2 YL)ACETATE; METHYL 2 [4 (4 BENZYLPHTHALAZIN 1 YLAMINO)BENZAMIDO] 3 ETHOXYACROLATE; N,N' BIS(4 BENZYLPHTHALAZIN 1 YL) 1,4 PHENYLENEDIAMINE; N,N' BIS(4 BENZYLPHTHALAZIN 1 YL)BIPHENYL 4,4' DIAMINE; N,N' BIS(4 BENZYLPHTHALAZIN 1 YL)ETHANE 1,2 DIAMINE; NORFLOXACIN; NYSTATIN; TETRACYCLINE; UNCLASSIFIED DRUG; [4 (4 BENZYLPHTHALAZIN 1 YLAMINO)BENZOYLAMINO]ACETIC ACID METHYLESTER;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS OCHRACEUS; BACILLUS CEREUS; BACILLUS SPHAERICUS; BACILLUS SUBTILIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; PENICILLIUM CHRYSOGENUM; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; SUBSTITUTION REACTION;

EID: 80052212673     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4081158     Document Type: Article

References (21)

1. Ito, S.; Yamaguchi, K.; Komoda, Y. Structural confirmation of the nitration product of the 1(2H)-phthalazinone as the 2-Nitro-1(2H)-phthalazinone. Chem. Pharm. Bull. 1992, 40, 3327-3329.
2. Haack, T.; Fattori, R.; Napoletano, M.; Pellacini, F.; Fronza, G.; Raffaini, G.; Ganazzoli, F. Phthalazine PDE IV inhibitors: Conformational study of some 6-methoxy-1,4-disubstituted derivatives. Bioorg. Med. Chem. 2005, 13, 4425-4433.
3. Heinisch, G.; Frank, H. In Progress in Medicinal Chemistry; Ellis, G.P., Luscombe, D.K., Eds; Elsevier: Amesterdam, The Netherlands, 1990; Volume 27, pp. 1-49.
4. Heinisch, G.; Frank, H. In Progress in Medicinal Chemistry; Ellis, G.P., Luscombe, D.K., Eds; Elsevier: Amesterdam, The Netherlands, 1992; Volume 29, pp. 141-1483.
5. Melikian, A.; Schiewer, G.; Chambon, J.P.; Wermuth, C.G. Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists. J. Med. Chem. 1992, 35, 4092-4197.
6. Napoletano, M.; Norcini, G.; Pellacini, F.; Morazzoni, G.; Ferlenga, P.; Pradella, L. Phthalazine PDE4 inhibitiors. Part 2: The synthesis and biological evolution of 6-methoxy-1,4-disubstituted derivatives. Bioorg. Med. Chem. Lett. 2001, 11, 33-37.
7. Kikuchi, K.; Nagano, T.; Hayakawa, H.; Hirata, Y.; Hirobe, M. Detection of nitric oxide production from a perfused organ by a luminol-hydrogen peroxide system. Anal. Chem. 1999, 22, 5131-5136.
8. Arakawa, H.; Ishida, J.; Yamaguchi, M.; Nakamura, M. Chemiluminescent products of reaction between a-Keto acids and 4,5-diaminophthalhydrazide. Chem. Pharm. Bull. 1990, 38, 3491-3499.
9. Arakawa, H.; Ishida, J.; Yamaguchi, M.; Nakamura, M. New chemiluminogenic substrate for N-Acetyl-ß-D-glucosaminidase, 4'-(6'-diethylamino-benzofuranyl)phthalylhydrazido-N-acetyl-ß- D-glucosaminide. Chem. Pharm. Bull. 1991, 39, 411-419.
10. Samoto, K.; Ohkura, Y. Ring expansion reaction of 1,3-dithiolanes and 1,3-oxathiolanes using tellurium tetrachloride. Chem. Lett. 1990, 19, 1323.
11. Tsoungas, P.G.; Searcey, M. A convenient access to benzo-substituted phthalazines as potential precursors to DNA intercalators. Tetrahedron Lett. 2001, 42, 6589-6592.
12. Sivakumar, R.; Gnanasam, S.K.; Ramachandran, S.; Leonard, J.T. Pharmacological evaluation of some new 1-substituted-4-hydroxy-phthalazines. Eur. J. Med. Chem. 2002, 37, 793-801.
13. Coelho, A.; Sotelo, E.; Fraiz, N.M.; Yanez, M.; Laguna, R.; Canob, E.; Ravina, E. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Bioorg. Med. Chem. Lett. 2004, 14, 321-324.
14. Demirayak, S.; Karaburun, A.C.; Beis, R. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Eur. J. Med. Chem. 2004, 39, 1089-1095.
15. Dogruer, D.S.; Sahin, M.F.; Unlu, S.; Ito, S. Studies on some 3(2H)-pyridazinone derivatives with antinociceptive activity. Arch. Pharm. 2000, 333, 79-86.
16. Dogruer, D.S.; Sahin, M.F.; Kupeli, E.; Yesilada, E. Synthesis and analgesic and anti-inflammatory activity of new pyridazinones. Turk. J. Chem. 2003, 27, 727-738.
17. Dogruer, D.S.; Sahin, M.F.; Kupeli, E.; Yesilada, E. Synthesis of new 2-[1(2H)-phthalazinon-2- yl]acetamide and 3-[1(2H)-phthalazinon-2-yl]propanamide derivatives as antinociceptive and anti-inflammatory agents. Arch. Pharm. 2004, 337, 303-310.
18. Sonmez, M.M.; Berber, I.; Akbas, E. Synthesis, antibacterial and antifungal activity of some new pyridazinone metal complexes. Eur. J. Med. Chem. 2006, 41, 101-105.
19. Condensed Pyridazines Including Cinnolines and Phthalazines; Castle, N.R., Ed.; Wiley-Intersicence: New York, NY, USA, 1973; p. 383.
20. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Microbiol. Infect. 2000, 6, 509-515.
21. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed.; Approved Standard M7-A5. NCCLS: Wayne, PA, USA, 2000.